Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis-Reference-Cited by-同舟云学术

Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis

Published:2020-06 Issue:6 Volume:2 Page:e347-e357
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Genovese Mark C,Smolen Josef S,Takeuchi Tsutomu,Burmester Gerd,Brinker Dennis,Rooney Terence P,Zhong Jinglin,Daojun Mo,Saifan Chadi,Cardoso Anabela,Issa Maher,Wu Wen-Shuo,Winthrop Kevin L

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference34 articles.

1. Chapter 24. Rheumatoid arthritis;Amaya-Amaya,2013

2. Progress in understanding the safety and efficacy of Janus kinase inhibitors for treatment of rheumatoid arthritis;Iwata;Expert Rev Clin Immunol,2016

3. Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050;Fridman;J Immunol,2010

4. JAKs and STATs in immunity, immunodeficiency, and cancer;O'Shea;N Engl J Med,2013

5. Baricitinib versus placebo or adalimumab in rheumatoid arthritis;Taylor;N Engl J Med,2017

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-rheumatology: the cardiovascular, pharmacological, and surgical risks associated with rheumatological diseases in women;Canadian Journal of Physiology and Pharmacology;2024-09-01

2. Baricitinib: key results of long-term use in rheumatoid arthritis;Modern Rheumatology Journal;2024-08-21

3. Wie gestalte ich die Basistherapie bei rheumatologischen Patient*innen mit maligner Vorerkrankung?;Aktuelle Rheumatologie;2024-06-18

4. Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study;Clinical and Experimental Medicine;2024-05-10

5. Risk of venous thromboembolism in patients with rheumatoid arthritis: a meta-analysis of observational studies;BMC Rheumatology;2024-02-02